Demirsoy Esra Terzi, Atesoglu Elif Birtas, Tarkun Pinar, Gedük Ayfer, Erdem Büşra Erşan, Hacihanefioglu Abdullah, Erçin Mehmet Cengiz
Department of Hematology, Kocaeli University School of Medicine, Umuttepe, Kocaeli 41380 Turkey.
Department of Patology, Kocaeli University School of Medicine, Umuttepe, Kocaeli 41380 Turkey.
Indian J Hematol Blood Transfus. 2016 Jun;32(Suppl 1):201-4. doi: 10.1007/s12288-015-0560-z. Epub 2015 Jun 5.
Isolated breast relapse after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is less often seen. Chronic graft-versus-host disease (cGVHD) is effective in preventing marrow relapse, but cGVHD seems not to be effective extramedullary relapse (EMR). We report the case of isolated breast relapse after first allo-HSCT for acute lymphoblastic leukemia (ALL). A 47-year-old female was diagnosed with ALL achieved complete remission with salvage chemotherapy and underwent allo-HSCT from an HLA-matched sibling male donor. At 17 months post-transplant, she presented with a bilateral breast masses that confirmed the diagnosis lymphoblast involvement. She had no evidence of leukemia in her marrow that determined 100 % full-donor chimerism when she was relapsed in her both breasts.
异基因造血干细胞移植(allo-HSCT)后孤立性乳腺复发较为少见。慢性移植物抗宿主病(cGVHD)对预防骨髓复发有效,但cGVHD似乎对髓外复发(EMR)无效。我们报告了1例急性淋巴细胞白血病(ALL)首次allo-HSCT后孤立性乳腺复发的病例。一名47岁女性被诊断为ALL,经挽救性化疗达到完全缓解,并接受了来自 HLA 配型相合的同胞男性供者的allo-HSCT。移植后17个月,她出现双侧乳腺肿块,确诊为淋巴母细胞浸润。当她双侧乳腺复发时,骨髓中无白血病证据,确定为100%完全供者嵌合。